These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25865119)

  • 1. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.
    Verfaillie A; Imrichova H; Atak ZK; Dewaele M; Rambow F; Hulselmans G; Christiaens V; Svetlichnyy D; Luciani F; Van den Mooter L; Claerhout S; Fiers M; Journe F; Ghanem GE; Herrmann C; Halder G; Marine JC; Aerts S
    Nat Commun; 2015 Apr; 6():6683. PubMed ID: 25865119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
    Shaffer SM; Dunagin MC; Torborg SR; Torre EA; Emert B; Krepler C; Beqiri M; Sproesser K; Brafford PA; Xiao M; Eggan E; Anastopoulos IN; Vargas-Garcia CA; Singh A; Nathanson KL; Herlyn M; Raj A
    Nature; 2017 Jun; 546(7658):431-435. PubMed ID: 28607484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
    Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
    Elife; 2015 Mar; 4():. PubMed ID: 25803486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells.
    Domenzain-Reyna C; Hernández D; Miquel-Serra L; Docampo MJ; Badenas C; Fabra A; Bassols A
    J Biol Chem; 2009 May; 284(18):12306-17. PubMed ID: 19269971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
    Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
    Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
    Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
    PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition.
    Gelato KA; Schöckel L; Klingbeil O; Rückert T; Lesche R; Toedling J; Kalfon E; Héroult M; Lejeune P; Mönning U; Fernández-Montalván AE; Bäurle S; Siegel S; Haendler B
    Oncogene; 2018 Jan; 37(4):512-521. PubMed ID: 28991225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
    Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of long and short enhancers in melanoma cell states.
    Mauduit D; Taskiran II; Minnoye L; de Waegeneer M; Christiaens V; Hulselmans G; Demeulemeester J; Wouters J; Aerts S
    Elife; 2021 Dec; 10():. PubMed ID: 34874265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
    Feng Y; Lee N; Fearon ER
    Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
    Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
    Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.